UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 348

Sortiert nach

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

Annals of oncology, 2014-09, Vol.25 (9), p.1729-1735

2014

Volltextzugriff (PDF)

Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis

International journal of cardiology, 2015-04, Vol.184, p.198-207

2015

Volltextzugriff (PDF)

TBX4 variants and pulmonary diseases: getting out of the 'Box'

Current opinion in pulmonary medicine, 2020-05, Vol.26 (3), p.277

2020

Volltextzugriff (PDF)

Physiological Interaction of Heart and Lung in Thoracic Irradiation

International journal of radiation oncology, biology, physics, 2012-12, Vol.84 (5), p.e639-e646

2012

Volltextzugriff (PDF)

Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study

International journal of cardiology, 2008-06, Vol.127 (1), p.27-32

2008

Volltextzugriff (PDF)

Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency

Pediatrics (Evanston), 2013-08, Vol.132 (2), p.e540

2013

Volltextzugriff (PDF)

Hypoxic/ischemic hits predispose to necrotizing enterocolitis in (near) term infants with congenital heart disease: a case control study

BMC pediatrics, 2020-12, Vol.20 (1), p.553-553, Article 553

2020

Volltextzugriff (PDF)

The Fontan circulation and the liver: A magnetic resonance diffusion-weighted imaging study

International journal of cardiology, 2016-01, Vol.202, p.595-600

2016

Volltextzugriff (PDF)

Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease

European heart journal, 2017-07, Vol.38 (26), p.2034-2041

2017

Volltextzugriff (PDF)

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

International journal of cardiology, 2016-01, Vol.202, p.52-58

2016

Volltextzugriff (PDF)

Egr-1 Expression During Neointimal Development in Flow-Associated Pulmonary Hypertension

The American journal of pathology, 2011-11, Vol.179 (5), p.2199-2209

2011

Volltextzugriff (PDF)

The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension

The Journal of pediatrics, 2020-10, Vol.225, p.65-73.e5

2020

Volltextzugriff (PDF)

Clinical Characterization of Pediatric Pulmonary Hypertension: Complex Presentation and Diagnosis

The Journal of pediatrics, 2009-08, Vol.155 (2), p.176-182.e1

2009

Volltextzugriff (PDF)

Pediatric Pulmonary Hypertension

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D117-D126

2013

Volltextzugriff (PDF)

Corrections to “Capturing intra-tumor genetic heterogeneity byde novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle”

Annals of oncology, 2018-11, Vol.29 (11), p.2268-2268

2018

Volltextzugriff (PDF)

Corrigendum to “FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion” [Int. J. Cardiol. 202 (2016) 52–58]

International journal of cardiology, 2016-11, Vol.223, p.1072-1073

2016

Volltextzugriff (PDF)

Overcoming drug resistance to Trk inhibition by rational combination of entrectinib and trametinib: from bench to bedside

European journal of cancer (1990), 2016-12, Vol.69, p.S5-S6

2016

Volltextzugriff (PDF)

Bosentan therapy in patients with eisenmenger syndrome : A multicenter, double-blind, randomized, placebo-controlled study

Circulation (New York, N.Y.), 2006-07, Vol.114 (1), p.48-54

2006

Volltextzugriff (PDF)

The challenges in paediatric pulmonary arterial hypertension

European respiratory review, 2014-12, Vol.23 (134), p.498-504

2014

Volltextzugriff (PDF)

Somatic mutations in small cell carcinoma of the ovary

Gynecologic oncology, 2014-06, Vol.133, p.107-107

2014

Volltextzugriff (PDF)

Deleterious Alterations in DNA Damage Response Genes Are Associated With Improved Outcome in Muscle-Invasive Bladder Cancer Patients Treated With Radiation-Based Bladder Preservation

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E248-E248

2015

Volltextzugriff (PDF)

Adverse pulmonary vascular remodeling in the Fontan circulation

The Journal of heart and lung transplantation, 2015-03, Vol.34 (3), p.404-413

2015

Volltextzugriff (PDF)

Persistent Pulmonary Hypertension of the Newborn With Transposition of the Great Arteries

The Annals of thoracic surgery, 2007-04, Vol.83 (4), p.1446-1450

2007

Volltextzugriff (PDF)

Robust Patient-Derived Xenografts (PDX) Capture the Disease Fidelity of Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML)

Leukemia research, 2017-04, Vol.55, p.S31-S32

2017

Volltextzugriff (PDF)

75 Loss of PTEN leads to acquired resistance to the PI3Ka inhibitor BYL719: a case of convergent evolution under selective therapeutic pressure

European journal of cancer (1990), 2014-11, Vol.50, p.29-29

2014

Volltextzugriff (PDF)

1 – 25 von 348

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(321)
Mit Volltextzugriff
(330)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(269)
Life Sciences & Biomedicine
(251)
Humans
(190)
Male
(121)
Cardiovascular System & Cardiology
(119)
Cardiac & Cardiovascular Systems
(118)
Female
(117)
Child
(72)
Biological And Medical Sciences
(67)
Pediatrics
(65)
Respiratory System
(55)
Adolescent
(52)
Adult
(52)
Medical Sciences
(52)
Child, Preschool
(51)
Pulmonary Hypertension
(49)
Animals
(44)
Heart
(43)
Congenital Heart Disease
(42)
Retrospective Studies
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis

TBX4 variants and pulmonary diseases: getting out of the 'Box'

Physiological Interaction of Heart and Lung in Thoracic Irradiation

Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study

Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency

Hypoxic/ischemic hits predispose to necrotizing enterocolitis in (near) term infants with congenital heart disease: a case control study

The Fontan circulation and the liver: A magnetic resonance diffusion-weighted imaging study

Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease

FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion

Egr-1 Expression During Neointimal Development in Flow-Associated Pulmonary Hypertension

The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension

Clinical Characterization of Pediatric Pulmonary Hypertension: Complex Presentation and Diagnosis

Pediatric Pulmonary Hypertension

Corrections to “Capturing intra-tumor genetic heterogeneity byde novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle”

Corrigendum to “FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion” [Int. J. Cardiol. 202 (2016) 52–58]

Overcoming drug resistance to Trk inhibition by rational combination of entrectinib and trametinib: from bench to bedside

Bosentan therapy in patients with eisenmenger syndrome : A multicenter, double-blind, randomized, placebo-controlled study

The challenges in paediatric pulmonary arterial hypertension

Somatic mutations in small cell carcinoma of the ovary

Deleterious Alterations in DNA Damage Response Genes Are Associated With Improved Outcome in Muscle-Invasive Bladder Cancer Patients Treated With Radiation-Based Bladder Preservation

Adverse pulmonary vascular remodeling in the Fontan circulation

Persistent Pulmonary Hypertension of the Newborn With Transposition of the Great Arteries

Robust Patient-Derived Xenografts (PDX) Capture the Disease Fidelity of Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML)

75 Loss of PTEN leads to acquired resistance to the PI3Ka inhibitor BYL719: a case of convergent evolution under selective therapeutic pressure

Suchergebnisse filtern